A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.

NCT06561555 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Mammary or Extramammary Paget's Disease

Interventions

DRUG: RC48

Sponsor

Fudan University